1. Home
  2. PGEN vs PAYO Comparison

PGEN vs PAYO Comparison

Compare PGEN & PAYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precigen Inc.

PGEN

Precigen Inc.

HOLD

Current Price

$7.70

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo Payoneer Global Inc.

PAYO

Payoneer Global Inc.

HOLD

Current Price

$7.11

Market Cap

2.4B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
PGEN
PAYO
Founded
1998
2005
Country
United States
United States
Employees
47
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.4B
IPO Year
2013
2021

Fundamental Metrics

Financial Performance
Metric
PGEN
PAYO
Price
$7.70
$7.11
Analyst Decision
Buy
Strong Buy
Analyst Count
5
8
Target Price
$8.33
$7.69
AVG Volume (30 Days)
3.7M
2.2M
Earning Date
05-13-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.03
0.05
Revenue
$230,981,000.00
$1,052,774,000.00
Revenue This Year
$1,115.92
$7.15
Revenue Next Year
$81.04
$10.28
P/E Ratio
$258.83
$142.20
Revenue Growth
N/A
7.68
52 Week Low
$2.99
$4.08
52 Week High
$8.04
$7.18

Technical Indicators

Market Signals
Indicator
PGEN
PAYO
Relative Strength Index (RSI) 64.70 51.98
Support Level $6.57 $7.08
Resistance Level $7.72 $7.16
Average True Range (ATR) 0.27 0.03
MACD 0.05 -0.01
Stochastic Oscillator 76.41 33.33

Price Performance

Historical Comparison
PGEN
PAYO

About PGEN Precigen Inc.

Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.

About PAYO Payoneer Global Inc.

Payoneer Global Inc is a financial technology company that enables small and medium-sized businesses (SMBs) to grow internationally through its diversified cross-border payments platform. It connects businesses, professionals, countries, and currencies, reducing the complexity of commerce and enabling customers to pay and get paid as easily as locally. The company offers a financial stack that includes cross-border AR/AP capabilities, funds management, working capital solutions, multicurrency accounts, and workforce management services. Its fully hosted platform provides multiple payment options with minimal integration, along with back-office functions and customer support. The company operates in Israel, the United States, and other countries.

Share on Social Networks: